retatrutide function The power of three: Retatrutide's

High protein, portion-controlled, ready in minutes

On average, semaglutide led to a placebo-corrected weight loss of about 12%, while tirzepatide reached an impressive 18% reduction in body weight

Mayo Clinic General patient education on phased dosing approaches for metabolic and weight management treatments

Reading Published Dose Ranges Correctly Retatrutides Phase 3 TRIUMPH-1 trial, with topline results reported by Eli Lilly in May 2026, evaluated three target doses 4mg, 9mg, and 12mg weekly with all arms starting at 2mg and escalating in steps every four weeks (2mg 4mg 6mg 9mg 12mg, depending on target arm) rather than starting at the target dose directly

This specific combination has not undergone the clinical trial process required for FDA approval

Match your needle to your injection site and body composition as described in the injection technique section above